Jennifer Michaelson Cullinan Oncology, Inc. (CGEM) insider trading activity

Jennifer Michaelson is Chief Scientific Officer of Cullinan Oncology, Inc.. Currently has a direct ownership of 142,004 shares of CGEM, which is worth approximately $1.24 Million. The most recent transaction as insider was on Apr 18, 2023, when has been sold 238 shares (Common Stock) at a price of $10.71 per share, resulting in proceeds of $2,548. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K

0% 3M change

9.59% 12M change

Total Value Held $1.24 Million

Jennifer Michaelson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 18 2023	SELL Open market or private sale	$2,548 $10.71 p/Share	238 Reduced 0.26%	90,879 Common Stock
Apr 12 2023	SELL Open market or private sale	$1,798 $10.22 p/Share	176 Reduced 0.19%	91,117 Common Stock
Mar 20 2023	SELL Open market or private sale	$2,694 $11.32 p/Share	238 Reduced 0.26%	91,293 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	-	38,500 Added 29.61%	91,531 Common Stock
Nov 25 2022	SELL Open market or private sale	$53,200 $13.3 p/Share	4,000 Reduced 7.01%	53,031 Common Stock
Nov 25 2022	BUY Exercise of conversion of derivative security	$17,200 $4.3 p/Share	4,000 Added 6.55%	57,031 Common Stock
Sep 27 2022	SELL Open market or private sale	$49,600 $12.4 p/Share	4,000 Reduced 7.01%	53,031 Common Stock
Sep 27 2022	BUY Exercise of conversion of derivative security	$17,200 $4.3 p/Share	4,000 Added 6.55%	57,031 Common Stock
Aug 08 2022	SELL Open market or private sale	$20,789 $15.01 p/Share	1,385 Reduced 2.55%	53,031 Common Stock
Aug 08 2022	BUY Exercise of conversion of derivative security	$5,956 $4.3 p/Share	1,385 Added 2.48%	54,416 Common Stock
Jul 25 2022	SELL Open market or private sale	$116,080 $14.51 p/Share	8,000 Reduced 13.11%	53,031 Common Stock
Jul 25 2022	BUY Exercise of conversion of derivative security	$34,400 $4.3 p/Share	8,000 Added 11.59%	61,031 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$17,658 $10.9 p/Share	1,620 Added 2.96%	53,031 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	28,500 Added 35.66%	51,411 Common Stock
Oct 18 2021	SELL Open market or private sale	$89,480 $22.37 p/Share	4,000 Reduced 14.86%	22,911 Common Stock
Oct 18 2021	BUY Exercise of conversion of derivative security	$17,200 $4.3 p/Share	4,000 Added 12.94%	26,911 Common Stock
Sep 20 2021	SELL Open market or private sale	$99,080 $24.77 p/Share	4,000 Reduced 14.86%	22,911 Common Stock
Sep 20 2021	BUY Exercise of conversion of derivative security	$17,200 $4.3 p/Share	4,000 Added 12.94%	26,911 Common Stock
Aug 18 2021	SELL Open market or private sale	$111,160 $27.79 p/Share	4,000 Reduced 14.86%	22,911 Common Stock
Aug 18 2021	BUY Exercise of conversion of derivative security	$17,200 $4.3 p/Share	4,000 Added 12.94%	26,911 Common Stock

Jennifer Michaelson

Chief Scientific Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Value

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cullinan Oncology, Inc.

Track Activities on CGEM

Account